Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of MyD88 in Tubular Epithelial Cells Alleviates the Cellular Senescence in Sepsis-Associated Acute Kidney Injury.

Inflammation·2026
Same author

The High School to University Transition: Exploring the interplay of territory, socioeconomic factors, and gender dynamics.

PloS one·2025
Same author

Retention Rates of Biological Drugs in Spondyloarthritis: A 24-Month Observational Study in Patients Aged 60 Years or Older.

Drugs - real world outcomes·2025
Same author

Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.

Cancer chemotherapy and pharmacology·2025
Same author

Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement-Monocentric Real-World Evidence.

Journal of clinical medicine·2025
Same author

Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2024

Related Experiment Video

Updated: May 30, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Assessing covariate imbalance in meta-analysis studies.

Fabio Aiello1, Massimo Attanasio, Fabio Tinè

  • 1Università Kore di Enna, Enna, Italy. fabio.aiello@unikore.it

Statistics in Medicine
|July 26, 2011
PubMed
Summary

This study introduces a novel statistical tool to detect covariate imbalance in clinical trials, enhancing meta-analysis by assessing trial similarity before data pooling. This method improves the reliability of combined study estimates.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 30, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Evidence Synthesis

Background:

  • Meta-analysis combines data from multiple studies to generate robust summary estimates.
  • Assessing the similarity of trials, particularly baseline covariate balance, is crucial for valid meta-analysis.
  • Existing methods may not adequately address covariate imbalance, especially with ties in data.

Purpose of the Study:

  • To propose a novel statistical tool for assessing covariate imbalance in baseline variables of randomized controlled trials (RCTs).
  • To investigate trial similarity and inform decisions regarding data pooling in meta-analysis.
  • To provide a quantitative method for evaluating the combinability of studies.

Main Methods:

  • Graphical comparison of empirical cumulative distribution functions (ECDFs) stratified by risk factors.
  • Application of non-parametric statistical tests (Kolmogorov-Smirnov, Anderson-Darling) on perturbed data to handle ties.
  • Validation using two real-world meta-analyses: interferon-alpha for chronic hepatitis C and statins for cholesterol lowering.

Main Results:

  • The proposed statistical tool effectively detects covariate imbalance in baseline variables.
  • Analysis of real meta-analyses demonstrated the tool's utility in assessing trial similarity and potential pooling issues.
  • The method can differentiate between balanced and imbalanced risk factors and identify structural differences in study variables.

Conclusions:

  • The developed statistical tool offers a quantitative approach to assess the combinability of RCTs in meta-analysis.
  • This method enhances the reliability of meta-analytic findings by ensuring the similarity of pooled studies.
  • While developed for RCTs, the approach may have applicability to non-randomized studies.